!!! New Impact Factor is out !!!

New JIF 2017: 6.629.





Society News

Welcome to the SFED!

ยป Find out more

Find out more

Current Issue August 2018

Lessons from pathological analysis of recurrent early esophageal squamous cell neoplasia after complete endoscopic radiofrequency ablation (FREE ACCESS)

Wen-Lun Wang, I-Wei Chang, Chien-Chuan Chen, Chi-Yang Chang, Cheng-Hao Tseng, Chi-Ming Tai, Jaw-Town Lin, Hsiu-Po Wang, Ching-Tai Lee


Study assessing use of radiofrequency ablation (RFA) for esophageal squamous neoplasia. The authors found a recurrence rate of 20 %, even in patients with complete response, probably due to the presence of deep esophageal glandular ductal involvement. RFA should be used with caution in squamous neoplasia.

Read more here.

Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial  (FREE ACCESS)

Jianfeng Yang, Jing Wang, Haibin Zhou, Yifeng Zhou, Yang Wang, Hangbin Jin, Qifeng Lou, Xiaofeng Zhang  et al.


In a randomized trial from China of patients with unresectable extrahepatic cholangiocarcinoma, except Bismuth type III and IV hilar tumors, it was found that radiofrequency ablation combined with biliary stenting increased stent patency and patient survival, without an increase in adverse events, compared with stent-only treatment.

Read more here.

Colon capsule versus computed tomography colonography for colorectal cancer screening in patients with positive fecal occult blood test who refuse colonoscopy: a randomized trial  (FREE ACCESS)

Mathieu Pioche, Christell Ganne, Rodica Gincul  et al.

This study examined the uptake of less invasive video capsule endoscopy or computed tomography colonography among patients with a positive guaiac fecal occult blood test who refused the recommended colonoscopy. Following an invitation letter, only 5% and 7% underwent the proposed procedure in the respective groups, and less than half of patients with positive findings accepted further colonoscopy.

Read more here.